Omega Therapeutics, Inc.
OMGAQ
$0.055
$0.0122.22%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 32.35% | 29.30% | 14.41% | 5.13% | -16.51% |
| Total Depreciation and Amortization | 15.92% | 5.41% | 38.11% | 30.46% | 48.04% |
| Total Amortization of Deferred Charges | -17.91% | -10.94% | -12.50% | -20.90% | 81.08% |
| Total Other Non-Cash Items | -1.42% | 5.94% | 3.84% | -3.98% | 12.25% |
| Change in Net Operating Assets | 129.38% | 72.27% | 101.69% | 5.22% | 40.83% |
| Cash from Operations | 43.66% | 35.69% | 27.18% | 7.11% | -9.33% |
| Capital Expenditure | -0.39% | -67.23% | -177.20% | -107.90% | -59.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -88.32% | -90.00% | -47.94% | 398.17% | 188.47% |
| Cash from Investing | -90.17% | -92.62% | -51.38% | 363.10% | 184.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.94% | -99.92% | -99.01% | 5,618.64% | 28,225.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 94.51% | -38.02% | -- | 60.44% |
| Cash from Financing | -104.91% | -101.39% | -98.11% | 5,807.20% | 449.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,097.11% | -506.57% | -3,920.60% | 98.13% | 103.27% |